Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Inhibitex Starts Veronate Hospital Infection Phase III Trial In Infants

July 1, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Taste Technology Firm Senomyx Goes Public With $36M Offering

June 23, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...